CS logo
small CS logo
Minsk City Clinical Oncology Dispensary

Minsk, Belarus

About Minsk City Clinical Oncology Dispensary


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Minsk City Clinical Oncology Dispensary


During the past decade, Minsk City Clinical Oncology Dispensary conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
2009-01-29
2023-09-21
Active, not recruiting
247
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
2009-09-01
Recruiting
360
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813

Rows per page:

1–100 of 191

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Minsk City Clinical Oncology Dispensary" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "AEterna Zentaris" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Jounce Therapeutics, Inc." with 1 trials sponsored and "Kevelt AS" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Minsk City Clinical Oncology Dispensary" #1 collaborator was "Belarusian State Medical University" with 1 trials as a collaborator and "Pharmasyntez" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Minsk City Clinical Oncology Dispensary


According to Clinical.Site data, the most researched conditions in "Minsk City Clinical Oncology Dispensary" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Dendritic Cells" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Minsk City Clinical Oncology Dispensary" in a lesser frequency.

Clinical Trials Intervention Types at Minsk City Clinical Oncology Dispensary


Most popular intervention types in "Minsk City Clinical Oncology Dispensary" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "AEZS-108 / zoptarelin doxorubicin" (1 trials), "BIBF 1120 plus docetaxel" (1 trials), "BIBW 2992" (1 trials), "Dendritic cells pulsed with MUC-1/WT-1 peptides" (1 trials) and "Dendritic cells pulsed with tumor lysate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Minsk City Clinical Oncology Dispensary


The vast majority of trials in "Minsk City Clinical Oncology Dispensary" are 6 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Minsk City Clinical Oncology Dispensary


Currently, there are NaN active trials in "Minsk City Clinical Oncology Dispensary". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Minsk City Clinical Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Minsk City Clinical Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status